Citation Impact
Citing Papers
Macrophages Mediate Inflammation-Enhanced Metastasis of Ovarian Tumors in Mice
2007
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With, CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study
2008
Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group
2008
Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study
2009
Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients
2008
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
2008
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
2010 StandoutScienceNobel
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Structural Roles for Human Translation Factor eIF3 in Initiation of Protein Synthesis
2005 StandoutScienceNobel
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.
2001
Hallmarks of Cancer: The Next Generation
2011 Standout
Gene expression profiling predicts clinical outcome of breast cancer
2002 StandoutNature
Translocations of the RARα gene in acute promyelocytic leukemia
2001
Risk-adapted postremission therapy in acute myeloid leukemia: results of the german multicenter AML HD93 treatment trial
2003
Structural views of phosphoinositide-specific phospholipase C: signalling the way ahead
1996
Cytogenetic, Molecular Genetic, and Clinical Characteristics of Acute Myeloid Leukemia With a Complex Karyotype
2008
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
Analysis of the genome to personalize therapy for melanoma
2010
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Acute lymphoblastic leukaemia
2008
Chromosome Aberrations, Gene Mutations and Expression Changes, and Prognosis in Adult Acute Myeloid Leukemia
2006
Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis
2005
Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility
1991 Nature
IL9 maps to mouse chromosome 13 and human chromosome 5
1990
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
1998 StandoutNature
Cytogenetics in acute leukemia
2003
Survival is poorer in patients with secondary core‐binding factor acute myelogenous leukemia compared with de novo core‐binding factor leukemia
2009
Prognostic Impact of Acute Myeloid Leukemia Classification: Importance of Detection of Recurring Cytogenetic Abnormalities and Multilineage Dysplasia on Survival
2003
Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
2008
Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances
2007
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
1991 StandoutNature
Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study
2005
Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia?
2003
Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222
2004
Acute myeloid leukaemia
2006
A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup
2002
Acute Myeloid Leukemia and the Position of Autologous Stem Cell Transplantation
2007
The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations
2006
Disruption of a Novel Imprinted Zinc-Finger Gene, ZNF215, in Beckwith-Wiedemann Syndrome
2000
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
1999
Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)
2006
Synaptotagmin I functions as a calcium regulator of release probability
2001 StandoutNatureNobel
The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease
1998
α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration
2005 StandoutNobel
Immunity, Inflammation, and Cancer
2010 Standout
Clinical relevance of cytogenetic abnormalities at diagnosis of acquired aplastic anaemia in adults
2006
Philadelphia Chromosome–Positive Acute Myeloid Leukemia
2007
Biology and management of relapsed acute myeloid leukaemia
2005
Nopp 140 shuttles on tracks between nucleolus and cytoplasm
1992 StandoutNobel
11q23 balanced chromosome aberrations in treatment‐related myelodysplastic syndromes and acute leukemia: Report from an International Workshop†
2002
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
2009 Standout
The control of growth and differentiation in normal and leukemic blood cells
1990
Localization of three genes expressed in retina on mouse Chromosome 11
1995
The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
2001
Use of Gene-Expression Profiling to Identify Prognostic Subclasses in Adult Acute Myeloid Leukemia
2004
Segmental expression of Hoxb-1 is controlled by a highly conserved autoregulatory loop dependent upon exd/pbx
1995 StandoutNobel
Growth factors in acute myeloid leukaemia
2001
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
The hormone resistin links obesity to diabetes
2001 StandoutNature
Beckwith–Wiedemann syndrome
2009
Clinical and biological importance of cytogenetic abnormalities in childhood and adult acute lymphoblastic leukemia
2004
Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy‐related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents
2001
Translational activation of the lck proto-oncogene
1988 StandoutNatureNobel
Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome
2004
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)
2002
Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction chemotherapy
2009
The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial
2002
NF-κB functions as a tumour promoter in inflammation-associated cancer
2004 StandoutNature
Cancer-related inflammation
2008 StandoutNature
Realistic Pathologic Classification of Acute Myeloid Leukemias
2001
Impact of Cytogenetics on Outcome of De Novo and Therapy-Related AML and MDS after Allogeneic Transplantation
2007
Interpreting cDNA sequences: Some insights from studies on translation
1996
Inflammation, inflammatory cells and angiogenesis: decisions and indecisions
2007
Molecular Diagnosis of the Hematologic Cancers
2003
Fluorescent indicators for Ca2+based on green fluorescent proteins and calmodulin
1997 StandoutNatureNobel
Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission
2005
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group
2009
The mouse and human genes encoding the recognition component of the N-end rule pathway
1998 StandoutNobel
Isolation and sequence of a cDNA corresponding to a src-related gene expressed in murine hemopoietic cells.
1987
Circular permutation and receptor insertion within green fluorescent proteins
1999 StandoutNobel
The CD14 Monocyte Differentiation Antigen Maps to a Region Encoding Growth Factors and Receptors
1988 Science
MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patients
2007
Overexpression of the ETS-Related Gene, ERG, Predicts a Worse Outcome in Acute Myeloid Leukemia With Normal Karyotype: A Cancer and Leukemia Group B Study
2005
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia
2002
Neurexin III alpha: extensive alternative splicing generates membrane-bound and soluble forms.
1993 StandoutNobel
6-Thioguanine, Cytarabine, and Daunorubicin (TAD) and High-Dose Cytarabine and Mitoxantrone (HAM) for Induction, TAD for Consolidation, and Either Prolonged Maintenance by Reduced Monthly TAD or TAD-HAM-TAD and One Course of Intensive Consolidation by Sequential HAM in Adult Patients at All Ages With De Novo Acute Myeloid Leukemia (AML): A Randomized Trial of the German AML Cooperative Group
2003
THE GREEN FLUORESCENT PROTEIN
1998 StandoutNobel
Integrins: Versatility, modulation, and signaling in cell adhesion
1992 Standout
Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype
2008
Treatment-Related Myelodysplasia and Acute Leukemia in Non-Hodgkin’s Lymphoma Patients
2003
GENETICS OF NON-INSULIN-DEPENDENT (TYPE-II) DIABETES MELLITUS
1996
Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B
2006
Cancer Cell Cycles
1996 StandoutScience
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Adult Patients With De Novo Acute Myeloid Leukemia and t(9; 11)(p22; q23) Have a Superior Outcome to Patients With Other Translocations Involving Band 11q23: A Cancer and Leukemia Group B Study
1997
Reconstructing the DNA Methylation Maps of the Neandertal and the Denisovan
2014 StandoutScienceNobel
Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?
2006
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
1997 StandoutScience
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study
2003
Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy:results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial
2007
Acute Myeloid Leukemia and Acute Promyelocytic Leukemia
2003
Prognostic value of cytogenetic findings in adults with acute myeloid leukemia.
2000
Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study
2006
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine
2001
Patients With t(8;21)(q22;q22) and Acute Myeloid Leukemia Have Superior Failure-Free and Overall Survival When Repetitive Cycles of High-Dose Cytarabine Are Administered
1999
Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets.
1991
Domain structure of a mammalian myosin I beta.
1994 StandoutNobel
Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B.
1990
Double-knockout mice for α- and β-synucleins: Effect on synaptic functions
2004 StandoutNobel
BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor
2001
pVHL 19 is a biologically active product of the von Hippel–Lindau gene arising from internal translation initiation
1998 StandoutNobel
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
1990 StandoutScience
CEBPA Mutations in Younger Adults With Acute Myeloid Leukemia and Normal Cytogenetics: Prognostic Relevance and Analysis of Cooperating Mutations
2004
An analysis of vertebrate mRNA sequences: intimations of translational control.
1991 Standout
Bcl-2 Cooperates with Promyelocytic Leukemia Retinoic Acid Receptor α Chimeric Protein (Pmlrarα) to Block Neutrophil Differentiation and Initiate Acute Leukemia
2001 Nobel
Novel Regulators of Bone Formation: Molecular Clones and Activities
1988 StandoutScience
Double Induction Containing Either Two Courses or One Course of High-Dose Cytarabine Plus Mitoxantrone and Postremission Therapy by Either Autologous Stem-Cell Transplantation or by Prolonged Maintenance for Acute Myeloid Leukemia
2006
Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup
2003
Genetic Dissection of Complex Traits
1994 StandoutScience
Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm
2002
The First Seven Amino Acids Encoded by the v-src Oncogene Act as a Myristylation Signal: Lysine 7 is a Critical Determinant
1988 StandoutNobel
Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations
2005
Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes.
1990 StandoutNobel
The Human Hematopoietic Colony-Stimulating Factors
1987 Science
daf-2 , an Insulin Receptor-Like Gene That Regulates Longevity and Diapause in Caenorhabditis elegans
1997 StandoutScienceNobel
Regulation of pp56lck during T-cell activation: functional implications for the src-like protein tyrosine kinases.
1987
Genomic analysis of orthologous mouse and human olfactory receptor loci
2001 StandoutNobel
Antagonism of Catecholamine Receptor Signaling by Expression of Cytoplasmic Domains of the Receptors
1993 StandoutScienceNobel
p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
1995
Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group
2007
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 Standout
The chromosomal distribution of mouse odorant receptor genes.
1996 StandoutNobel
Disclosure of Candidate Genes in Acute Myeloid Leukemia With Complex Karyotypes Using Microarray-Based Molecular Characterization
2006
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
The scanning model for translation: an update.
1989 Standout
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
2000
A receptor guanylyl cyclase expressed specifically in olfactory sensory neurons.
1995 StandoutNobel
Individual Patient Data–Based Meta-Analysis of Patients Aged 16 to 60 Years With Core Binding Factor Acute Myeloid Leukemia: A Survey of the German Acute Myeloid Leukemia Intergroup
2004
Comparison of Cytogenetic and Molecular Cytogenetic Detection of Chromosome Abnormalities in 240 Consecutive Adult Patients With Acute Myeloid Leukemia
2002
Coordinated assembly of human translation initiation complexes by the hepatitis C virus internal ribosome entry site RNA
2004 StandoutNobel
Prognostic Impact of Acute Myeloid Leukemia Classification
2003
Works of Mark J. Pettenati being referenced
Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201
2007
A genetic map of chromosome 20q12-q13.1: multiple highly polymorphic microsatellite and RFLP markers linked to the maturity-onset diabetes of the young (MODY) locus.
1993
Absence of HER2 overexpression in metastatic malignant melanoma
2003
Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors
1989
Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia—retrospective study and review of literature
2004
Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.
1997
Bone marrow cytogenetic abnormalities of aplastic anemia
2001
The human NACP/α-synuclein gene: chromosome assignment to 4q21.3–q22 and TaqI RFLP analysis
1995
cDNA Sequence and Gene Locus of the Human Retinal Phosphoinositide-Specific Phospholipase-Cβ4 (PLCB4)
1995
Localization of amplified MYC gene sequences to double minute chromosomes in acute myelogenous leukemia
1994
Comparison of Cytogenetic and Molecular Genetic Detection of t(8;21) and inv(16) in a Prospective Series of Adults With De Novo Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
2001
Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461
2006
Wiedemann-Beckwith syndrome: presentation of clinical and cytogenetic data on 22 new cases and review of the literature
1986
Genetic and physical mapping of human recoverin: a gene expressed in retinal photoreceptors.
1994
Detection of abnormal pretransplant clones in progenitor cells of patients who developed myelodysplasia after autologous transplantation.
1999
Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B Study
2005
Transferable anticancer innate immunity in spontaneous regression/complete resistance mice
2006
Identification of a Human Gene (HCK) that Encodes a Protein-Tyrosine Kinase and is Expressed in Hemopoietic Cells
1987
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
1998
Assignment of CSF-1 to 5q33.1: evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disorders.
1987
Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience.
1999
Central Review of Cytogenetics Is Essential for Cooperative Group Clinical and Correlative Studies of Acute Leukemia: The Cancer and Leukemia Group B (CALGB) 8461 Experience.
2004
Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from Cancer and Leukemia Group B 8461.
1998
Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: Results from Cancer and Leukemia Group B 8461
2002
Abnormal Cytogenetics at Date of Morphologic Complete Remission Predicts Short Overall and Disease-Free Survival, and Higher Relapse Rate in Adult Acute Myeloid Leukemia: Results From Cancer and Leukemia Group B Study 8461
2004
Repetitive Cycles of High-Dose Cytarabine Benefit Patients With Acute Myeloid Leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): Results from CALGB 8461
2004
Outcome of Induction and Postremission Therapy in Younger Adults With Acute Myeloid Leukemia With Normal Karyotype: A Cancer and Leukemia Group B Study
2004